A security audit by IT firm Dreamlab Technologies has found more than 2.5 million potential vulnerabilities in the IT infrastructure connected to the public Internet in Switzerland.
“That’s definitely too much. Switzerland is not doing its job properly when it comes to cybersecurity,” said IT expert Marc Peter when asked by the Keystone-SDA news agency. Peter is a professor at the University of Applied Sciences Northwestern Switzerland and CEO of Dreamlab Technologies.
The study into Swiss cyberspace was presented on Tuesday on the occasion of the Swiss Cyber Security Days. The company Dreamlab Technologies used the CyObs software solution to scan the “external attack surface” and inventory all IT infrastructures connected to the Internet.
Around a million of these potential vulnerabilities were classified as critical or high. “These are vulnerabilities that are documented and known to hackers,” said Peter. These are security gaps in software that have already been discovered, reported and listed in a database.
According to the investigation, the security gaps affect all areas. An analysis carried out by Dreamlab a year ago showed that in Switzerland the financial sector was particularly well protected, while research, education and healthcare brought up the rear.
“Even the federal administration is affected,” said Peter. In the current investigation, the experts found various gaps in “admin.ch” websites. According to the IT expert, most of the security gaps in the Internet infrastructure of the Swiss federal administration can be traced back to outdated versions of software products.
These security gaps could be exploited by cybercriminals, for example to blackmail people or companies, steal industrial secrets or publish fake news, as Peter explained.
“It’s like going on vacation as a private individual without closing the windows of your apartment,” said Peter. According to the expert, politicians as well as private individuals and companies must address these security problems.
Translated from German by DeepL/mga
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
This content was published on
There is no longer any danger of rockfall or landslide on the roads below the Graubünden village of Brienz, authorities say.
This content was published on
Europe’s biggest freshwater fish tastes better than its reputation, say fishermen in the French-speaking west of Switzerland.
Swiss authorities keep close eye on West Nile fever in Italy
This content was published on
Authorities are keeping a close eye on the situation after the death toll in Italy due to the disease has risen to seven.
Bern biodiversity project brings boost for forest bees
This content was published on
More sunlit areas in forests can boost the number of wild bees – both in overall terms and in terms of species diversity.
Swiss president kicks off National Day celebrations on Rütli meadow
This content was published on
Several hundred people gathered on the Rütli in central Switzerland at midday on Friday to celebrate the national Swiss holiday, before Karin Keller-Sutter addressed the crowd.
US sets deadline for Novartis and other pharma firms to lower prices
This content was published on
US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug prices in the United States – or face retaliation.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.